Results 201 to 210 of about 21,588 (222)
Effectiveness and Safety of Switching to Ravulizumab From Eculizumab in Kidney Transplant Recipients With Atypical Hemolytic Uremic Syndrome: A Global aHUS Registry Analysis. [PDF]
Clin TransplantGaeckler A +7 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Improving the outcome for children with cancer: Development of targeted new agents
Ca-A Cancer Journal for Clinicians, 2015Peter C Adamson
exaly
Complement, a target for therapy in inflammatory and degenerative diseases
Nature Reviews Drug Discovery, 2015exaly
Clinical promise of next-generation complement therapeutics
Nature Reviews Drug Discovery, 2019Daniel Ricklin, John D Lambris
exaly